Climb Bio, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
CLYM$11.01+7.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $25,803 | $87,229 |
| Short-term marketable securities | 61,098 | 63,690 |
| Prepaid expenses and other current assets | 4,063 | 3,953 |
| Total current assets | 90,964 | 154,872 |
| Long-term marketable securities | 88,930 | 61,610 |
| Operating lease right-of-use assets | 562 | 490 |
| Property and equipment, net | 318 | 199 |
| Other long-term assets | 1,530 | 16 |
| Total assets | $182,304 | $217,187 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $477 | $705 |
| Accrued expenses and other current liabilities | 4,244 | 4,069 |
| Operating lease liabilities | 228 | 157 |
| Total current liabilities | 4,949 | 4,931 |
| Operating lease liabilities, net of current portion | 352 | 375 |
| Total liabilities | 5,301 | 5,306 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value; 250,000,000 shares authorized; 68,184,435 and 67,255,434 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 7 | 7 |
| Additional paid-in capital | 448,738 | 441,727 |
| Accumulated other comprehensive income | 469 | 23 |
| Accumulated deficit | (272,211) | (229,876) |
| Total stockholders’ equity | 177,003 | 211,881 |
| Total liabilities and stockholders’ equity | $182,304 | $217,187 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.